Latanoprost Upjohn Uk (Latanoprost)

Latanoprost is a prostaglandin F2α analogue that activates FP receptors in the eye’s ciliary body. This activation increases uveoscleral outflow of aqueous humor, allowing fluid to drain more efficiently and thereby lowering intraocular pressure.

The dosing regimen for Latanoprost Upjohn Uk is determined by the prescribing clinician. Typically, one drop is instilled into the affected eye(s) once daily in the evening, but the exact schedule must follow the prescriber’s instructions.

Safety data for Latanoprost in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any potential risk to the fetus or infant, and the decision must be made by the treating physician.

To place an order, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Latanoprost belongs to the prostaglandin analogue class, which generally offers once‑daily dosing and strong intraocular pressure reduction. Compared with beta‑blocker or carbonic anhydrase inhibitor drops, prostaglandin analogues often have a more favorable dosing convenience but may cause distinctive cosmetic changes such as iris darkening.

Latanoprost should be stored at room temperature, below 25 °C, in its original packaging. Protect the bottle from light and moisture, and keep the cap tightly closed when not in use.

Latanoprost is applied as an ophthalmic solution. The patient places a single drop into the prescribed eye(s) once daily, preferably in the evening, and avoids touching the tip of the bottle to the eye or any other surface.

Serious risks, though rare, include severe ocular inflammation (uveitis or iritis), paradoxical increase in intraocular pressure, corneal edema, and allergic reactions that may affect the eyelids or surrounding skin. Any sudden vision changes or pain should prompt immediate medical evaluation.

Patients with active ocular infections, known hypersensitivity to latanoprost or any component of the formulation, or those who have had a severe reaction to other prostaglandin analogues should avoid using this medication. The prescriber should assess suitability on an individual basis.